Certara Consultants to Present PK/PD Modeling Advances at the AAPS Annual Meeting and Exposition

Certara will participate in 10 seminars and forums, launch the new version of its Phoenix PK/PD software platform, and support the National Organization for Rare Disorders during the show. PRINCETON, NJ – Oct. 31, 2014 – Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that its Simcyp® and Pharsight® consultants … Continued

Certara Receives FDA Grant to Enhance Simcyp Simulator’s Mechanistic Dermal Absorption Model

Enhanced solution will be able to model additional populations, and diseases, and also consider new mechanisms that impact dermal absorption. ST. LOUIS, MO – Oct. 23, 2014 – Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs … Continued

Reasons to Attend Certara’s CADD, PK/PD, and PBPK Modeling Courses

As the manager of scientific communication for Certara, part of my job is to educate new and existing clients on the ways they can maximize their utilization of Certara’s software and consulting services. Therefore, it was important for me, early on, to experience our training solutions to better understand our clients’ perspectives. At Certara, we … Continued